|4Oct 27, 9:04 PM ET

PINNEY ALESIA LEE 4

4 · AVALARA, INC. · Filed Oct 27, 2021

Insider Transaction Report

Form 4
Period: 2021-10-26
Transactions
  • Sale

    Common Stock

    2021-10-26$181.29/sh3,419$619,83143,390 total
  • Sale

    Common Stock

    2021-10-26$181.94/sh3,605$655,89439,785 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-10-262,3157,408 total
    Exercise: $39.76Exp: 2029-01-28Common Stock (2,315 underlying)
  • Exercise/Conversion

    Common Stock

    2021-10-26$67.27/sh+243$16,34746,809 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-10-264,6593,727 total
    Exercise: $16.60Exp: 2028-01-23Common Stock (4,659 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-10-262437,272 total
    Exercise: $67.27Exp: 2030-03-12Common Stock (243 underlying)
  • Exercise/Conversion

    Common Stock

    2021-10-26$16.60/sh+4,659$77,33944,251 total
  • Exercise/Conversion

    Common Stock

    2021-10-26$39.76/sh+2,315$92,04446,566 total
  • Sale

    Common Stock

    2021-10-26$182.85/sh193$35,29039,592 total
Footnotes (6)
  • [F1]The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2021.
  • [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $180.65 to $181.59, inclusive. Upon request by the Issuer, any security holder thereof, or the staff of the Securities and Exchange Commission, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
  • [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $181.70 to $182.51, inclusive.
  • [F4]25% of the total shares subject to the option vested and became exercisable on January 1, 2019, and 1/48th of the total shares subject to the option vest and become exercisable monthly thereafter such that the option is fully vested and exercisable on January 1, 2022.
  • [F5]25% of the total shares subject to the option vested and became exercisable on January 1, 2020, and 1/48th of the total shares subject to the option vest and become exercisable monthly thereafter such that the option is fully vested and exercisable on January 1, 2023.
  • [F6]25% of the total shares subject to the option vested and became exercisable on March 5, 2021, and 1/48th of the total shares subject to the option vest and become exercisable monthly thereafter such that the option is fully vested and exercisable on March 5, 2024.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION